FDA publishes guidance on device changes:
This article was originally published in Clinica
The US FDA has published a draft guidance document entitled "Deciding when to submit a 510(k) for a change to an existing device". The document includes a flowchart model which can be used by manufacturers to help decide whether modifications to a device necessitate a new 510(k) submission (see Clinica No 671, p 5). Contact: Division of Small Manufacturers Assistance, CDRH (HFZ-220), FDA, 1350 Piccard Drive, Rockville, MD 20850. Tel: (301) 443 6597. Fax: (301) 443 8818. Comments on the guidance should be sent by December 15th to Dockets Management Branch (HFA-305), FDA, Rm 1-23, 12420 Parklawn Drive, Rockville, MD 20857.
You may also be interested in...
SK set for Korean trial with vaccine, as Biological E begins human trials of Baylor vaccine. Meanwhile, DongWha gets a Phase II nod for potential drug, and Celltrion progesses with Phase II regdanvimab trial.
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.
As Bharat Biotech prepares its COVID-19 vaccine for a launch in the quarter ending next 30 September and claims at least 60% efficacy, questions arise over why trials were not temporarily halted following a serious adverse event during Phase I and why this wasn’t disclosed to participants in subsequent studies.